Diucifonum treatment of patients with systemic scleroderma

R. Sh. Abdrakhmanova , I. L. Bilich , M. M. Mangusheva , L. K. Bombina , G. M. Khalfieva

Kazan medical journal ›› 1986, Vol. 67 ›› Issue (2) : 96 -98.

PDF
Kazan medical journal ›› 1986, Vol. 67 ›› Issue (2) : 96 -98. DOI: 10.17816/kazmj65308
Articles
research-article

Diucifonum treatment of patients with systemic scleroderma

Author information +
History +
PDF

Abstract

The treatment of patients with systemic scleroderma is still a challenging task for internal medicine clinics. This paper presents the results of the therapeutic efficacy of diucciphone in such patients at different periods of observation. Diucciphone (2,4 dioxo-6-methylpyrimidinyl-5-sulfonoamido)-diphenylsulfone is an antileprosy drug synthesized at the A.E. Arbuzov Institute of Organic and Physical Chemistry, KFAN of the USSR.

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
R. Sh. Abdrakhmanova, I. L. Bilich, M. M. Mangusheva, L. K. Bombina, G. M. Khalfieva. Diucifonum treatment of patients with systemic scleroderma. Kazan medical journal, 1986, 67(2): 96-98 DOI:10.17816/kazmj65308

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ермаков Е. В., Коломеец H. М., Голощапов H. М. и др. Тер. арх., 1983, 3.

RIGHTS & PERMISSIONS

Abdrakhmanova R.S., Bilich I.L., Mangusheva M.M., Bombina L.K., Khalfieva G.M.

AI Summary AI Mindmap
PDF

114

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/